First Participant Enrolled in Phase 3 Trial of Fasedienol for Social Anxiety Disorder : vimarsana.com

Vistagen has enrolled the first participant in the PALISADE-3 phase 3 trial of fasedienol for the treatment of social anxiety disorder.

Related Keywords

New York State Psychiatric Institute , New York , United States , Columbia University , Shawn Singh , Michaelr Liebowitz , York State Psychiatric Institute , Drug Administration , Research Network , Fast Track , Subjective Units , Distress Scale , Liebowitz Social Anxiety Scale , Anxiety Disorders Clinic , Medical Research Network , Tales From , Anxiety Disorder , Vistagen Therapeutics Fast Track Designation ,